FF
MRNA icon

FourThought Financial’s Moderna MRNA Stock Holding History

FourThought Financial’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$20K Hold
168
– – ﹤0.01% 861
2022
Q2 		$24K Sell
168
-8
-5% -$1.14K ﹤0.01% 821
2022
Q1 		$30K Buy
176
+115
+189% +$19.4K ﹤0.01% 808
2021
Q4 		$15K Buy
+61
New +$17.8K ﹤0.01% 991

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FourThought Financial's MRNA Position: Q3 2022 in Review

FourThought Financial held its Moderna (MRNA) position steady in Q3 2022 at 168 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #861.

FourThought Financial first reported a position in MRNA in Q4 2021 and has held it in 4 quarters since. The position peaked at $30K in Q1 2022. 916 funds tracked by Wall St. Rank hold MRNA as of Q3 2022.

  • FourThought Financial held 168 shares of Moderna worth $20K as of Q3 2022.
  • FourThought Financial left its Moderna share count unchanged in Q3 2022.
  • Moderna made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #861 holding.
  • FourThought Financial first reported a position in Moderna in Q4 2021 and has held it in 4 quarters since.
  • FourThought Financial's Moderna position peaked at $30K in Q1 2022.
  • 916 funds tracked by Wall St. Rank held Moderna as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.